1. Home
  2. DCTH vs NWTN Comparison

DCTH vs NWTN Comparison

Compare DCTH & NWTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • NWTN
  • Stock Information
  • Founded
  • DCTH 1988
  • NWTN 2016
  • Country
  • DCTH United States
  • NWTN United Arab Emirates
  • Employees
  • DCTH N/A
  • NWTN N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • NWTN Auto Manufacturing
  • Sector
  • DCTH Health Care
  • NWTN Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • NWTN Nasdaq
  • Market Cap
  • DCTH 630.4M
  • NWTN 625.3M
  • IPO Year
  • DCTH N/A
  • NWTN N/A
  • Fundamental
  • Price
  • DCTH $16.30
  • NWTN $1.86
  • Analyst Decision
  • DCTH Strong Buy
  • NWTN
  • Analyst Count
  • DCTH 4
  • NWTN 0
  • Target Price
  • DCTH $24.00
  • NWTN N/A
  • AVG Volume (30 Days)
  • DCTH 610.5K
  • NWTN 3.4M
  • Earning Date
  • DCTH 05-08-2025
  • NWTN 01-01-0001
  • Dividend Yield
  • DCTH N/A
  • NWTN N/A
  • EPS Growth
  • DCTH N/A
  • NWTN N/A
  • EPS
  • DCTH N/A
  • NWTN N/A
  • Revenue
  • DCTH $53,850,000.00
  • NWTN $43,867,000.00
  • Revenue This Year
  • DCTH $141.47
  • NWTN N/A
  • Revenue Next Year
  • DCTH $49.31
  • NWTN N/A
  • P/E Ratio
  • DCTH N/A
  • NWTN N/A
  • Revenue Growth
  • DCTH 1068.87
  • NWTN 7424.36
  • 52 Week Low
  • DCTH $6.33
  • NWTN $0.30
  • 52 Week High
  • DCTH $18.23
  • NWTN $3.56
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 58.68
  • NWTN 58.47
  • Support Level
  • DCTH $15.73
  • NWTN $1.50
  • Resistance Level
  • DCTH $17.29
  • NWTN $2.36
  • Average True Range (ATR)
  • DCTH 0.96
  • NWTN 0.57
  • MACD
  • DCTH -0.08
  • NWTN -0.01
  • Stochastic Oscillator
  • DCTH 50.58
  • NWTN 43.63

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About NWTN NWTN Inc.

NWTN Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world. Geographically, it operates in The United States, The United Arab Emirates, Mainland China.

Share on Social Networks: